Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
2024年9月5日 - 9:00PM
Enovis™ (NYSE: ENOV), an innovation-driven medical technology
company, announced today it will unveil its new Tarsoplasty
Percutaneous Lapidus System and offer live demonstrations of Better
Step, a patient-focused platform, alongside other advanced product
offerings at the American Orthopaedic Foot & Ankle Society®
(AOFAS) annual meeting in Vancouver, British Columbia from
September 11–14, 2024.
“Our expanding portfolio continues to deliver solutions
that drive better patient outcomes and surgical efficiency,” said
Gary Justak, President and General Manager of Enovis Foot &
Ankle. “This year, we’re reinforcing that Enovis is not just
keeping pace with the rapidly evolving foot and ankle
landscape—we’re driving it into the fast lane.”
At the meeting, Enovis will unveil the Tarsoplasty Percutaneous
Lapidus System, an innovative approach to the Lapidus bunionectomy
that features next generation instruments and implants for a more
guided, reproducible percutaneous procedure—enabling surgeons to
reduce operative time and improve recovery outcomes for
patients.
“The clinical data supporting the Tarsoplasty System highlights
the effectiveness of the percutaneous approach to hallux valgus
correction,” stated Shannon Cummings, Global Vice President of
Marketing for Enovis Foot & Ankle. “We’re confident that this
system will showcase our expertise in percutaneous foot and ankle
surgery and our dedication to enhancing these procedures
broadly.”
In addition to the Tarsoplasty System, Enovis will offer live
demonstrations of Better Step, a patient-focused platform designed
to enhance the patient experience throughout the bunion surgery
journey. The app encourages physicians to deliver personalized care
through custom videos, educational materials, and recovery
protocols tailored to each patient’s needs.
“We are thrilled to showcase Tarsoplasty and Better Step at
AOFAS,” said Justak. “These offerings exemplify our commitment to
empowering surgeons and enabling patients to take an active role in
their recovery journey.”
The company will also showcase an array of advanced solutions
from its comprehensive foot and ankle continuum, including:
- DynaNail® TTC – TTC Fusion System
- Evolve34™ – Lapidus Correction System
- Arsenal Foot Plating System – (Now featuring expanded plating
options and Type II anodized titanium alloy).
- Tiger Cannulated Screw System – (Now featuring a new hexalobe
screw head design).
- DonJoy® Velocity® + Ankle Brace – Ankle Brace
- Aircast AirSelect Elite – Pneumatic Walking Boot
AOFAS attendees have opportunities throughout the week to
experience these product offerings firsthand.
- Visit Enovis booth #104 in the exhibit hall.
- Educational presentations from Drs. Samuel Adams and
Christopher Gross on demand virtually, “The Use of Highly Variable
Angle Screws increased Compression in Orthopaedic Plating” and
in-person on Sept. 12 at 1:30 PM: “Biomechanical Advantages of
sustained Dynamic compression over static Fixation in Subtalar
Arthrodesis.”
About Enovis
Enovis™ (NYSE: ENOV) is an innovation-driven medical technology
growth company dedicated to developing clinically differentiated
solutions that generate measurably better patient outcomes and
transform workflows. Powered by a culture of continuous
improvement, global talent and innovation, the company’s extensive
range of products, services, and integrated technologies fuels
active lifestyles in orthopedics and beyond. For more information
about Enovis, please visit www.enovis.com.
Media Contacts
Diana Aldermae, Enovis™ Foot & Ankle
Diana.Aldermae@enovis.com
Leda Buster, Enovis™ Bracing & Supports
Leda.Buster@enovis.com
Enovis (NYSE:ENOV)
過去 株価チャート
から 10 2024 まで 11 2024
Enovis (NYSE:ENOV)
過去 株価チャート
から 11 2023 まで 11 2024